LING MA, MD
Hematology & Oncology Physician · LAKEWOOD, CO
Individual Active NPI 1063617454
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 620 | 252,614 | $16,562,188 | $4,063,650 | $3,257,521 |
| 2023 | 599 | 245,847 | $15,724,474 | $4,038,928 | $3,227,781 |
| 2022 | 566 | 210,267 | $13,165,492 | $3,089,540 | $2,472,385 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 29,760 | $0 | $0 |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 18,720 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 16,840 | $31 | $25 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,800 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,400 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 7,100 | $56 | $45 |
| J1756 | Injection, iron sucrose, 1 mg | 5,800 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 5,760 | $25 | $20 |
| J0185 | Injection, aprepitant, 1 mg | 3,640 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,240 | $0 | $0 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,800 | $46 | $37 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,100 | $20 | $16 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 49174 | CO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Colorado
- NPI 1972587533
- NPI 1851267306
- NPI 1629067012
- NPI 1407812043
- NPI 1851994073
- NPI 1013991736
- NPI 1790818425
- NPI 1285618504
See all Hematology & Oncology Physician providers in Colorado →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.